Brooklyn ImmunoTherapeutics Inc (BTX) To Go Ex-Dividend on March 14th

Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) announced a monthly dividend on Monday, March 3rd, NASDAQ Dividends reports. Stockholders of record on Friday, March 14th will be given a dividend of 0.0862 per share on Monday, March 31st. This represents a $1.03 annualized dividend and a dividend yield of 15.76%. The ex-dividend date is Friday, March 14th.

Brooklyn ImmunoTherapeutics Trading Up 2.0 %

Brooklyn ImmunoTherapeutics stock traded up $0.13 during trading hours on Wednesday, hitting $6.56. 121,478 shares of the stock traded hands, compared to its average volume of 824,850. Brooklyn ImmunoTherapeutics has a one year low of $6.35 and a one year high of $8.31. The company has a market cap of $385.90 million, a PE ratio of -2.89 and a beta of 4.61. The firm’s 50-day moving average price is $2.25 and its two-hundred day moving average price is $1.41.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Brooklyn ImmunoTherapeutics in a research report on Thursday, March 6th. They set a “hold” rating for the company.

About Brooklyn ImmunoTherapeutics

Eterna Therapeutics, Inc is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.